Protokoly_diagnostiki_i_lechenia_zabolevany
.pdf" ( ) 4 ;
7." IgE;
8." IgE – B_? – .
" & :
1.& ;
2.& ;
3.B " ;
4." ;
6. ! .
" & & :
1.& ;
2.& ;
3.H)B $ .
+ |
: H" #$ & # |
||||
" , |
# $" . |
||||
B$" ( ) |
( &, & % |
||||
. .). !$# 3 |
$" |
|
: |
||
2-3 |
( 25 , 3 100 , |
10,0). @ |
|||
" |
|
|
" ( 1 |
||
/ ) & . , $# |
|
# . ' % " |
|||
3 " |
|
, |
"$ |
||
" 1-4 & ( 30 / , & 1% , 15-30 ).
! & % " &$ % ,&$ % , , , " % . % && % " , 3 . < &% : 3 - " 1% ,$# & 3-6 , %$ , , ( " ), " % & $ ( 250 ). ' " %&$ " ( , &, , & ).
& |
( |
), , $ % |
( 1%-10,0; |
0,5%-10,0; 0,1; 3 15 , & 0,1). ! &$$ & ( / & . ). @
" &$ |
" . H " & |
||||||
" |
|
& |
% |
|
|||
, % "-" |
3 |
" " |
|
|
|||
$ 3 |
% |
|
|||||
, "$ (3 1 50 |
|
50,0 1- 3 |
|||||
&), % |
( |
0,5 ). H" , " & |
|||||
"$ /+!, , & & " 3 , % ( "$ ) – 10 "& 0,0005 "&.
" & :
1.*J 10 .; & 15 ;
2.*/ 10 .;
3.* & 0,5%;
4.* 1% , ;
5.; 15 ;
6./ 15-30 ;
7.? & 15,0;
8.*; & 30% 10 ;
9. *6 4 .; 40 , 125 , 250 , 500 V ;
10.* , % 4 500 >@;
11.*< 1 .;
" & & :
1. * 0,01 .;
3.*_ 0,01 .;
4.7 1 . 50 . 50,0;
,- ! :
!- " .
6 ( ? &, B-&, 6 ).
/ |
, & : |
1. |
" $# " , & |
, 2- . 7 ;?-6>@, 2002, !. 909-911. |
|
2. |
?topic eczema. Dominic Smethurst and Sarah Macfarlane, May 2002. http: www.guidlines.gov. |
* – , # (% % )
7 8
: 15-138
"$ &: " :
& ! :
1. & "- " , #
; |
|
|
|
2. |
& ; |
||
3. . |
|||
' & & : 17 |
|
||
(: |
P23 ' % |
|
|
|
P23.0 |
' % |
|
|
P23.1 |
' % |
, |
|
P23.2 |
' % |
, |
|
P23.3 |
' % |
, ' |
|
P23.4 |
' % |
, " " |
|
P23.5 |
' % |
, Pseudomonas |
|
P23.6 |
' % |
, & |
|
|
|
|
|
P23.8 |
' % |
, |
|
P23.9 |
' % |
" |
) : 7 8 ( ) –, $# &
& . |
|
|
|
|
|
|
|
$ : ' |
|
$: |
|||||
1. ' % |
( & |
|
|
||||
" ); 3 " |
|
||||||
, , |
, |
, , , |
|||||
., , , $ % . |
|
|
|||||
2.' % & , , |
|
||||||
|
: , % |
||||||
. |
|
|
|
|
|
|
|
' % |
& |
|
" $ |
|
|
||
3 , $ & (Mycoplasma hominis,
Ureaplasma urealyticum), 3 , " |
|
' |
|||||
D, – # , & |
|||||||
" , . |
|
|
|
|
|
|
|
B & , |
|
% |
|
|
, |
||
$ |
|
', |
, |
& |
|
||
, , II , Candida, % # , 3 , 3 , & " , , .
* :
" , , " & ;
" & % # ;
|
& |
, ; |
|
& % ; |
|
|
. |
|
" : 3 . |
|
|
" |
: |
|
, " & % %).
3. :
/ ( 20 / ). > $ – % & " (5 / &).
4. % ( 25° !).
@ & , " % ," . " , %(« -»). % %" 24 " % 3 , &.
5. .
+ & & & % %$# , , ". ! %$# . > , & .
6.# & " $ &$. > %, & % (20 / ) #&$ & , " " , % " 8-12 .
7..
. > & $ % 2,2 &/ (< 45 / ), 10 / 10% $* " &" .
8. 6 .
6 % & % 6 " ( % 3 " , " & ). ' " % & &. >& " , .
" & :
1. *? 250 .; 250 , 500 .; 5001000 V ; 125/5 ;
2.*? + 625 .; 600 V ;
3.* 40 / , 80 /2 .;
4. |
*/ 250 , 500 , 1 000 , |
V ; |
|
5. |
*/ 250 , 500 , .; 750 , |
V ; |
|
6. |
*/ 1 000 V ; |
8.? 200 , 800 .;
9.*! & + 120 , ,480 , .; 480 /5 , .; 240 /5 & ;
10.* 500 , .;
11. *7 250 , 500 , .; 250 /5 & ;
12.*! 1,5 >@, 375 >@, ; 750 >@, 1,5 >@,;
13.*6 250 , .; 0,5 100 ;
14.* 0,25 , ;
15.*_ 50 , 150 , .; 100 / ;
16.*! & 100 / , 3 &; 2 , 4 .; 20 ;
17.*B 100 3 &;
18.*_ 5 , .; 0,5 /10 V ;
19.*@ 4 / , V ; 500 , .;
20. *@ 62,5 , 250 , ,; 1 0,025% V .
" & & :
1. |
*? 125 , 500 , ; 250 ; 200 |
/100 |
; |
|
|
2. |
*@ 0,5%, 4% 5 V ; |
|
/ |
, & : |
|
1.Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.
2.Tice AD, Rehm SJ, Dalovisio JR, Bradley JS, Martinelli LP, Graham DR, Brooks Gainer R, Kunkel MJ, Yancey RW, Williams DN. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis 2004 Jun 15;38(12):1651-72.
3.- $ # %
- http://www.healthquality.ru/flowcharts/pihrus.pdf
4. ' & % .. ' ), 6) , 2003, 197 .
* – , # (% % )
* :
1. & ( "-" , " 3 ,, " );
2." &;
3.% & ;
4./+!;
5.;
6.;
7.;
" : 3 , |
|
" |
: |
1." # ;
2.& "$;
3." ;
4." 3 ;
:
1." ;
2.;
3.% &;
4.$;
5.77 ;
6.& & ;
7." .
" & :
1.7 3 ;
2.# ;
3.# " .
" & & :
1. &$ ; 2.O ; 3. & & ;
4.& ;
5.& ;
6.? ;
7.< " .
+ :
", 3 " , % &, $" , " . < &
& |
" |
% |
||||
3 . |
|
|
|
|
|
|
J " 3 "$ & |
" . $ |
|||||
& , " 3 |
" & |
|
. |
|||
J " 3 % # & 3 , |
||||||
|
– 3 |
|
. ! |
|||
|
¼ " . |
|
|
|||
" |
¾ " " 2-3 &. |
|||||
" 3 " .3 " " 1 . &" " % % & 3
" 3 . " 3, . " % " 3 " " 3 && % & % ". ) % & " 2- – 4- & " % . )
?7 % & # – 1-2 . 3 |
|
||||||
% & & 1 . " . |
|
|
|||||
; - 3 " |
|
||||||
7. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 " |
|
|
|
||
|
|
1- |
|
2- |
3- |
|
|
;-" |
' & |
|
@ * |
|
|
|
|
|
|
|
|
_ |
|
|
|
|
|
|
|
J % * |
|
|
|
" |
|
' & |
|
@ * |
|
|
|
|
|
|
|
J % * |
|
|
|
" |
|
' & |
|
_ |
|
|
|
" |
' & |
|
J % * |
|
|
|
|
|
|
|
|
! |
|
|
|
|
|
|
|
_* |
|
|
|
" |
|
' & |
|
* |
|
|
|
? |
|
|
|
|
|
|
|
; " |
|
' & |
|
* |
|
|
|
|
|
! |
|
* |
|
|
|
? " |
|
' & |
|
* |
|
|
|
|
|
|
|
||||
|
|
J % * |
|
* |
|
|
|
6 " |
' & |
|
* |
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
) & |
$ |
|
|
|
|
|
|
! |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
! |
|
|
|
|
|
|
|
+ & |
|
' & |
|
_* |
|
|
|
" |
|
|
* |
|
|
|
|
3 |
|
|
|
|
|
|
|
B & |
|
' & |
|
* |
|
|
|
3 " |
|
_* |
|
|
|
|
|
3 |
|
|
|
|
|
|
|
% |
|
_* |
|
' & |
|
|
|
& |
|
|
|
|
|
|
|
! ' |
|
' & |
|
* |
< & |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
+ * |
J % |
|
|
|
|
|
|
|
|
|
|
! |
J- |
' & |
J % * |
|
|
|
|
|
|
|
|
B |
|
|
|
! |
J- |
' & |
|
|
|
|
|
|
" |
; * |
! |
|
|
|
|
|
|
J % * |
< |
|
B |
|
|
|
|
|
_ |
|
|
; |
- |
|
|
|
|
|
|
|
|
6 " |
' & |
* |
|
|
|
||
" 3 |
|
|
* |
|
|
|
|
|
|
|
|
|
|
||
? |
! |
' & |
|
|
|
||
? |
|
|
' & |
@ * |
|
? ( |
|
"$# |
|
|
J % * |
|
) |
|
|
|
|
|
|
|
|
||
-" |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
? |
|
|
' & |
' & |
|
|
|
|
|
|
" |
|
|
|
|
|
|
|
|
|
|
|
|
6 " |
' & |
J % * |
|
@ |
|
||
$& |
|
|
|
|
|
|
|
" |
|
|
|
|
|
||
7 |
|
|
' & |
J % * |
|
|
|
% |
|
_* |
|
|
|
|
|
|
|
|
|
|
|
||
-" |
|
|
|
|
|
||
|
|
|
|
|
|
|
|
! " ?7 ( / / ):
_ 3-5; 20; * 5-8; (3 15-30); * 0,1; & 30-80; % * 2-5; 0,05-0,3-1,0; 5-15-30; * 5-10-20.
" & :
1.*' & 150 , 300 , 500 .;
2.500 ,1000 .;
3.200 .;
4.7 150-300 .;
5.* 25 , 100 .;
6.50-150-300 .;
7.*? 50-100-200 .;
" & & :
1.*@ 80 .;
2.*_ 50 , 100 .;
3.*J % 25 , 50 .;
,- ! - :
1.% ;
2.& .
